Agency Emergency Information Collection Clearance Request for Public Comment, 23836-23837 [2020-09039]
Download as PDF
<![CDATA[
23836
Federal Register / Vol. 85, No. 83 / Wednesday, April 29, 2020 / Notices
following summary of a proposed
collection for public comment.
Comments on the ICR must be
received on or before May 29, 2020.
DATES:
Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 795–7714. When submitting
comments or requesting information,
please include the document identifier
0990-New-30D and project title for
reference.
Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
SUPPLEMENTARY INFORMATION:
Title of the Collection: Substance Use
Disorder Patient Placement Criteria
Used By States.
Type of Collection: New.
The Office of the Assistant Secretary
for Planning and Evaluation (ASPE) at
the U.S. Department of Health and
Human Services (HHS) is requesting
Office of Management and Budget
(OMB) approval for a one-time survey of
state agencies regarding their use of
substance use disorder (SUD) patient
placement criteria and assessment tools.
The proposed survey is one component
of a larger project to assess the
feasibility of gathering and utilizing
needs assessment data to identify and
address unmet patient needs by levels of
care. Results from this survey will
provide ASPE with information about
the types of patient placement data
states collect and maintain, and the
degree to which the data can be used to
understand the SUD treatment gap.
These results will provide ASPE with
information that can be used to develop
a multistate dataset of needs assessment
that can be updated over time. Such a
dataset is necessary for understanding
and addressing treatment needs in the
nation on an ongoing basis.
The 17-question survey requests
information related to state
requirements for using patient
placement criteria and assessment tools
for individuals with SUD. Additional
questions ask how data from the
placement criteria and/or assessment
tools are maintained; if level of care data
has been used to help determine service
gaps and need for greater capacity; and
whether the respondent could provide
weblinks to available information on the
criteria used in their state.
Two individuals from each state and
the District of Columbia will be invited
to respond to the survey. Respondents
will be representatives from each state’s
Single State Authority (SSA) and the
Medicaid Agency. An eighty-five
percent response rate is anticipated,
resulting in an estimated 87 total
participants.
This project falls under Section 301 of
the Public Health Service Act (42U.S.C.
241) [280–1a] which authorizes the
Office of the Secretary to conduct and
coordinate studies relating to the causes,
diagnosis, treatment, control, and
prevention of physical and mental
diseases.
The total annual burden hours
estimated for this information collection
request are summarized in the table
below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Forms
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(hours)
Total annual
burden
(hours)
Survey on SUD Placement Criteria .................................................................
87
1
10/60
14.5
Sherrette A. Funn,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. 2020–09108 Filed 4–28–20; 8:45 am]
BILLING CODE 4151–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier OS–0990–New]
Agency Emergency Information
Collection Clearance Request for
Public Comment
Office of the Secretary, HHS.
Notice.
AGENCY:
jbell on DSKJLSW7X2PROD with NOTICES
ACTION:
In compliance with the requirement
of the Paperwork Reduction Act of 1995,
the Office of the Secretary (OS),
Department of Health and Human
Services, is publishing the following
summary of a proposed information
collection request for public comment.
Interested persons are invited to send
VerDate Sep<11>2014
20:00 Apr 28, 2020
Jkt 250001
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, email your request,
including your address, phone number,
OMB number, and OS document
identifier, to Sherrette.funn@hhs.gov, or
call the Reports Clearance Office on
(202) 795–7714. Written comments and
recommendations for the proposed
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
information collections must be directed
to the OS Paperwork Clearance Officer
at the above email address within 7days.
Proposed Project: COVID–19 by PCR
Requisition Form.
OMB No. 0990–NEW.
Emergency Information Collection
Clearance Request
Office: HHS, Office of the Assistant
Secretary for Health, Office of the
Surgeon General.
Abstract: The COVID–19 by PCR
Requisition Form will be used to collect
information from individuals who are
participating in the federally supported,
state managed, locally executed CBTS
program to obtain COVID–19 laboratory
testing. The COVID–19 by PCR
Requisition Form will be used by
approximately 200,000 individuals. The
Lab Requisition form includes the
ordering physician information, the
laboratory account information, the date
of collection, the time of collection; the
E:\FR\FM\29APN1.SGM
29APN1
23837
Federal Register / Vol. 85, No. 83 / Wednesday, April 29, 2020 / Notices
individual’s last name, first name, date
of birth, gender, language, race,
ethnicity, address, phone number,
insurance carrier name, and whether the
individual has provided informed
consent and received a copy of the
privacy notice. The information from
the Lab Requisition form is shared with
the ordering provider, the contracted
laboratory companies, the cognizant
state health department, and the
contracted call center. Aggregate data is
shared with HHS and FEMA.
ESTIMATED ANNUALIZED BURDEN TABLE
Type of respondent
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Individuals receiving COVID–19 testing ..........................................................
200,000
1
.1
20,000
[FR Doc. 2020–09039 Filed 4–28–20; 8:45 am]
Dated: April 23, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4150–36–P
[FR Doc. 2020–09047 Filed 4–28–20; 8:45 am]
Sherrette A. Funn,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Clinical
Cognitive Screening.
Date: May 18, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892. (Telephone Conference
Call)
Contact Person: Greg Bissonette, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, BETHESDA,
MD 20892, (301) 402–1622, bissonettegb@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
20:00 Apr 28, 2020
Jkt 250001
Dated: April 23, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–09049 Filed 4–28–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
and Hematology Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group Digestive Diseases and
Nutrition DDK–C Subcommittee.
Date: June 17–19, 2020.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6706
Democracy Blvd., Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, Division of Extramural Activities,
NIDDK, National Institutes of Health, Room
7017, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7637, davilabloomm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel;
P41 BTRC Review F–SEP.
Date: June 10–12, 2020.
Time: 09:00 a.m. to 05:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Rockville, MD 20852.
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, National
Institute of Biomedical Imaging, and
Bioengineering, National Institutes of
Health, 6707 Democracy Blvd.,
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 85, Number 83 (Wednesday, April 29, 2020)]
[Notices]
[Pages 23836-23837]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09039]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier OS-0990-New]
Agency Emergency Information Collection Clearance Request for
Public Comment
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
In compliance with the requirement of the Paperwork Reduction Act
of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
information collection request for public comment. Interested persons
are invited to send comments regarding this burden estimate or any
other aspect of this collection of information, including any of the
following subjects: (1) The necessity and utility of the proposed
information collection for the proper performance of the agency's
functions; (2) the accuracy of the estimated burden; (3) ways to
enhance the quality, utility, and clarity of the information to be
collected; and (4) the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, email your
request, including your address, phone number, OMB number, and OS
document identifier, to [email protected], or call the Reports
Clearance Office on (202) 795-7714. Written comments and
recommendations for the proposed information collections must be
directed to the OS Paperwork Clearance Officer at the above email
address within 7-days.
Proposed Project: COVID-19 by PCR Requisition Form.
OMB No. 0990-NEW.
Emergency Information Collection Clearance Request
Office: HHS, Office of the Assistant Secretary for Health, Office
of the Surgeon General.
Abstract: The COVID-19 by PCR Requisition Form will be used to
collect information from individuals who are participating in the
federally supported, state managed, locally executed CBTS program to
obtain COVID-19 laboratory testing. The COVID-19 by PCR Requisition
Form will be used by approximately 200,000 individuals. The Lab
Requisition form includes the ordering physician information, the
laboratory account information, the date of collection, the time of
collection; the
[[Page 23837]]
individual's last name, first name, date of birth, gender, language,
race, ethnicity, address, phone number, insurance carrier name, and
whether the individual has provided informed consent and received a
copy of the privacy notice. The information from the Lab Requisition
form is shared with the ordering provider, the contracted laboratory
companies, the cognizant state health department, and the contracted
call center. Aggregate data is shared with HHS and FEMA.
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Individuals receiving COVID-19 testing...... 200,000 1 .1 20,000
----------------------------------------------------------------------------------------------------------------
Sherrette A. Funn,
Office of the Secretary, Paperwork Reduction Act Reports Clearance
Officer.
[FR Doc. 2020-09039 Filed 4-28-20; 8:45 am]
BILLING CODE 4150-36-P
